Global Biosimulation Market Size study, By Product, By Application, By Delivery Model, By End-Use, and Regional Forecasts 2022-2028

List of Tables

Global Biosimulation Market is valued at approximately USD 2.4 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.2% over the forecast period 2022-2028.

The use of computer software to simulate biological processes is known as biosimulation. A predictive and analytical tool called biosimulation is used in the drug discovery process to forecast the results of ongoing experimental trials. By running illness simulations, virtual clinical trials of novel pharmacological medications under development can be carried out. Biosimulation software has several uses in the pharmaceutical drug discovery and development process since it can help pharmaceutical companies find novel medications faster and more affordably. Increasing need to reduce drug discovery and development costs, as well as increasing investments in the life sciences industry, are factors that are accelerating the global market demand. For instance, in a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilizing the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The goal of the trial was to expedite the repurposing of therapies for pulmonary hypertension and the development of COVID-19-fighting medications. Consequentially, increasing use of personalized medicine and rising technological advancements stimulate market growth in the approaching years. However, a lack of skills & expertise impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Biosimulation market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of key market players, increasing adoption of digitalization in healthcare, and rising prevalence of chronic diseases. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising research and development activities, and rising initiatives by public and private players would create lucrative growth prospects for the Biosimulation market across the Asia Pacific region.

Major market players included in this report are:

Certara, USA

Simulations Plus

Dassault Systemes

Schrodinger, Inc.

Advanced Chemistry Development

Chemical Computing Group ULC

Physiomics Plc

Rosa & Co. LLC

Biosimulation Consulting Inc.

Genedata AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Software

Services

By Application:

Drug Development

Drug Discovery

Others

By Delivery Model:

Subscription Models

Ownership Models

By End-Use:

Pharmaceutical & Biotechnology Companies

CROs

Regulatory Authorities

Academic Research Institutions

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Biosimulation Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Biosimulation Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Biosimulation Market, by Product, 2020-2028 (USD Billion)
- 1.2.3. Biosimulation Market, by Application, 2020-2028 (USD Billion)
- 1.2.4. Biosimulation Market, by Delivery Model, 2020-2028 (USD Billion)
- 1.2.5. Biosimulation Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Biosimulation Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Biosimulation Market Dynamics

3.1. Biosimulation Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing need to reduce drug discovery and development costs
  - 3.1.1.2. Increasing investments in the life sciences industry
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of skills and expertise
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing use of personalized medicine
  - 3.1.3.2. Rising Technological advancements

Chapter 4. Global Biosimulation Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biosimulation Market, by Product

6.1. Market Snapshot
6.2. Global Biosimulation Market by Product, Performance - Potential Analysis
6.3. Global Biosimulation Market Estimates & Forecasts by Product, 2018-2028 (USD Billion)
6.4. Biosimulation Market, Sub Segment Analysis
- 6.4.1. Software
- 6.4.2. Services

Chapter 7. Global Biosimulation Market, by Application

7.1. Market Snapshot
7.2. Global Biosimulation Market by Application, Performance - Potential Analysis
7.3. Global Biosimulation Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
7.4. Biosimulation Market, Sub Segment Analysis
- 7.4.1. Drug Development
- 7.4.2. Drug Discovery
- 7.4.3. Others

Chapter 8. Global Biosimulation Market, by Delivery Model

8.1. Market Snapshot
8.2. Global Biosimulation Market by Delivery Model, Performance - Potential Analysis
8.3. Global Biosimulation Market Estimates & Forecasts by Delivery Model, 2018-2028 (USD Billion)
8.4. Biosimulation Market, Sub Segment Analysis
- 8.4.1. Subscription Models
- 8.4.2. Ownership Models

Chapter 9. Global Biosimulation Market, by End-Use

9.1. Market Snapshot
9.2. Global Biosimulation Market by End-Use, Performance - Potential Analysis
9.3. Global Biosimulation Market Estimates & Forecasts by End-Use, 2018-2028 (USD Billion)
9.4. Biosimulation Market, Sub Segment Analysis
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. CROs
- 9.4.3. Regulatory Authorities
- 9.4.4. Academic Research Institutions

Chapter 10. Global Biosimulation Market, Regional Analysis

10.1. Biosimulation Market, Regional Market Snapshot
10.2. North America Biosimulation Market
- 10.2.1. U.S. Biosimulation Market
  - 10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
  - 10.2.1.2. Application breakdown estimates & forecasts, 2018-2028
  - 10.2.1.3. Delivery model breakdown estimates & forecasts, 2018-2028
  - 10.2.1.4. End-Use breakdown estimates & forecasts, 2018-2028
- 10.2.2. Canada Biosimulation Market
10.3. Europe Biosimulation Market Snapshot
- 10.3.1. U.K. Biosimulation Market
- 10.3.2. Germany Biosimulation Market
- 10.3.3. France Biosimulation Market
- 10.3.4. Spain Biosimulation Market
- 10.3.5. Italy Biosimulation Market
- 10.3.6. Rest of Europe Biosimulation Market
10.4. Asia-Pacific Biosimulation Market Snapshot
- 10.4.1. China Biosimulation Market
- 10.4.2. India Biosimulation Market
- 10.4.3. Japan Biosimulation Market
- 10.4.4. Australia Biosimulation Market
- 10.4.5. South Korea Biosimulation Market
- 10.4.6. Rest of Asia Pacific Biosimulation Market
10.5. Latin America Biosimulation Market Snapshot
- 10.5.1. Brazil Biosimulation Market
- 10.5.2. Mexico Biosimulation Market
10.6. Rest of The World Biosimulation Market

Chapter 11. Competitive Intelligence

11.1. Top Market Strategies
11.2. Company Profiles
- 11.2.1. Certara, USA
  - 11.2.1.1. Key Information
  - 11.2.1.2. Overview
  - 11.2.1.3. Financial (Subject to Data Availability)
  - 11.2.1.4. Product Summary
  - 11.2.1.5. Recent Developments
- 11.2.2. Simulations Plus
- 11.2.3. Dassault Systemes
- 11.2.4. Schrodinger, Inc.
- 11.2.5. Advanced Chemistry Development
- 11.2.6. Chemical Computing Group ULC
- 11.2.7. Physiomics Plc
- 11.2.8. Rosa & Co. LLC
- 11.2.9. Biosimulation Consulting Inc.
- 11.2.10. Genedata AG

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Biosimulation Market, report scope
TABLE 2. Global Biosimulation Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Biosimulation Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Biosimulation Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 5. Global Biosimulation Market estimates & forecasts by Delivery Model 2018-2028 (USD Billion)
TABLE 6. Global Biosimulation Market estimates & forecasts by End-Use 2018-2028 (USD Billion)
TABLE 7. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Biosimulation Market
TABLE 57. List of primary sources, used in the study of global Biosimulation Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

FIG 1. Global Biosimulation Market, research methodology
FIG 2. Global Biosimulation Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biosimulation Market, key trends 2021
FIG 5. Global Biosimulation Market, growth prospects 2022-2028
FIG 6. Global Biosimulation Market, porters 5 force model
FIG 7. Global Biosimulation Market, pest analysis
FIG 8. Global Biosimulation Market, value chain analysis
FIG 9. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Biosimulation Market, regional snapshot 2018 & 2028
FIG 15. North America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 16. Europe Biosimulation Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Biosimulation Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 19. Global Biosimulation Market, company Market share analysis (2021)